-5%
Embardia (Darbepoetin alfa) is indicated for the treatment of anemia due to:
- Chronic Kidney Disease (CKD) in patients on dialysis and those not on dialysis.
- Anemia in patients receiving myelosuppressive chemotherapy, with at least two additional months of planned chemotherapy upon treatment initiation.

